Join us on Thursday, 24 September 2026 for our upcoming ANZ-LCNF webinar, Optimal Therapy Management of Amivantamab in Non-Small Cell Lung Cancer.
This session will explore how to support patients receiving amivantamab treatment, covering optimal therapy management and strategies for managing potential adverse reactions.
This webinar is proudly sponsored by Johnson & Johnson.